Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial

Fig. 1

Study Schema. Patients with T1–2N0M0 non-small cell lung cancer and co-existing fibrotic interstitial lung disease will be enrolled in this single-arm study. Analysis will be stratified by interstitial lung disease severity. NSCLC: non-small cell lung cancer, ILD: interstitial lung disease, ILD-GAP: interstitial lung disease – gender/age/physiology model

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us